Josh Narrow is named as a lobbyist on federal disclosure filings for 8 clients through The Conafay Group, LLC. The most recent filing naming them posted in October 2026. Issues reported include Medical/Disease Research/Clinical Labs, Health Issues, Budget/Appropriations and Disaster Planning/Emergencies.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| REVAGENIX, INC. | THE CONAFAY GROUP, LLC | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| BRIGHT PATH LABORATORIES, INC. | THE CONAFAY GROUP, LLC | Q3 2026 | Medical/Disease Research/Clinical Labs |
| PKX BIO | THE CONAFAY GROUP, LLC | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) | THE CONAFAY GROUP, LLC | Q3 2026 | Health Issues |
| ELUSYS THERAPEUTICS, INC | THE CONAFAY GROUP, LLC | Q3 2026 | Medical/Disease Research/Clinical Labs |
| MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG) | THE CONAFAY GROUP, LLC | Q3 2026 | Medical/Disease Research/Clinical Labs, Budget/Appropriations |
| CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP | THE CONAFAY GROUP, LLC | Q1 2026 | Health Issues |
| LIFESCIENCE LOGISTICS | THE CONAFAY GROUP, LLC | Q3 2025 | Disaster Planning/Emergencies, Medical/Disease Research/Clinical Labs |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 7 | 1 |
| 2025 | 6 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 1 | $500 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Josh Narrow. See the Capitol Clarity rankings and method.